Myriad Genetics beat estimated earnings by 180.0%, reporting an EPS of $0.04 versus an estimate of $-0.05. Revenue was down $800 thousand from the same period last year. In the previous quarter, the ...

Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular testing and precision medicine, will hold its fourth quarter and full year 2025 earnings conference call at 4:30 pm ET on Monday, Feb. 23, ...

Opus Genetics targets inherited retinal diseases with one-dose AAV gene augmentations. Read why IRD stock is a Buy.

SALT LAKE CITY, UT / ACCESS Newswire / March 10, 2026 / Path FertilityTM, an epigenetics-driven fertility technology ...

The bipolar depression market is anticipated to increase during the forecast period (2026--2036), owing to the rise in the launch of emerging therapies such as Azetukalner (Xenon Pharmaceuticals), ...

A new U.S. autism research panel is examining potential causes of autism, sparking debate over science, policy, and the ...

Cannabis cultivation at home has grown beyond a hobby-it’s now a movement for enthusiasts who want full control over what they grow and consume. Buying cannabis seeds online sounds simple, but the ...

Knowable Magazine reports that equine cloning has transformed polo in Argentina, raising ethical questions amid industry ...

The best way to learn something is to experience it. Even in relationships, you can read advice or watch romantic movies, thinking they'll teach you what to expect, but it’s not the same as feeling ...

This study presents a valuable finding on the mutational order for common alterations in colorectal cancer. The evidence of in vitro growth assays comparing mutations is solid, although inclusion of ...

4D Molecular Therapeutics, Inc. ( FDMT) TD Cowen 46th Annual Health Care Conference March 3, 2026 10:30 AM EST ...

The "Cell and Gene Therapy Manufacturing Market -- Growth, Share, Opportunities & Competitive Analysis, 2024 -- 2032" report has been added to the Credence Research Inc. offering. The global Cell and ...